Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Osteoporosis × Myeloid × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 10 Genitourinary 9 Other hematologic neoplasm 3 Lymphoid 2 Myeloid 1 Endocrine 1 Classical hematology 1

Conditions

Myelodysplastic Syndromes 77 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 65 Leukemia, Myeloid, Acute 57 Leukemia 56 Myeloproliferative Disorders 53 Precursor Cell Lymphoblastic Leukemia-Lymphoma 39 Primary Myelofibrosis 34 Leukemia, Myeloid, Chronic-Phase 34 Leukemia, Myelomonocytic, Chronic 33 Polycythemia Vera 28 Lymphoma 26 Multiple Myeloma 24 Lymphoma, Non-Hodgkin 24 Leukemia, Lymphocytic, Chronic, B-Cell 23 Lymphoma, Large B-Cell, Diffuse 22 Hodgkin Disease 22 Lymphoma, Mantle-Cell 21 Burkitt Lymphoma 21 Leukemia, Myeloid, Accelerated Phase 20 Blast Crisis 20 Lymphoma, Large-Cell, Immunoblastic 19 Lymphoma, Follicular 19 Lymphoma, B-Cell, Marginal Zone 19 Thrombocythemia, Essential 18 Lymphoma, T-Cell, Cutaneous 16 Leukemia, Hairy Cell 16 Neoplasms, Plasma Cell 15 Myelodysplastic-Myeloproliferative Diseases 15 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 15 Waldenstrom Macroglobulinemia 12

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03401060 2024-05-03

DenosuMast

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

Osteoporosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡